NewsAvicenna.AI Receives European CE Mark Approval for its CINA-VCF Quantix and CINA-CSpineByRidhi RastogiJune 6, 20250Comments
NewsHUTCHMED and Innovent Biologics Report NMPA’s NDA Acceptance of Fruquintinib + Sintilimab for Renal Cell CarcinomaByRidhi RastogiJune 5, 20250Comments
NewsAkeso’s Cadonilimab Receives the NMPA’s Approval for 1L Treatment of Cervical CancerByRidhi RastogiJune 5, 20250Comments
NewsAlvotech Collaborates with Dr. Reddy’s to Co-Develop a Biosimilar Version of KeytrudaByRidhi RastogiJune 5, 20250Comments
NewsCullinan Therapeutics Enters a ~$712M Licensing Deal with Genrix Bio for VelinotamigByRidhi RastogiJune 5, 20250Comments
NewsThe EC Approves Roche’s Evrysdi Tablet for Spinal Muscular AtrophyByRidhi RastogiJune 5, 20250Comments
NewsEli Lilly Licenses Camurus’ FluidCrystal Technology to Advance Long-Acting Incretin ProductsByRidhi RastogiJune 5, 20250Comments
